Immunotherapy drug delays cancer recurring or worsening in global trial
A new study found the drug kept head and neck cancers at bay for five years compared to 30 months with standard care
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
